New combo therapy aims to shrink eye tumors before surgery
Disease control
Not yet recruiting
This early-phase trial tests whether giving two immunotherapy drugs (nivolumab and ipilimumab) before eye removal surgery is safe and feasible for people with high-risk uveal melanoma, a rare eye cancer. About 15 participants will receive the drugs and then undergo surgery. The s…
Phase: PHASE1 • Sponsor: Inge Marie Svane • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC